NCT04574596 (SHREC) is a clinical trial of no Intervention in E Coli Infection, sponsored by Duke University.

Who is sponsoring NCT04574596?

NCT04574596 is sponsored by Duke University.

What drugs are being tested in NCT04574596?

Interventions in NCT04574596: no Intervention.

What condition does NCT04574596 study?

NCT04574596 studies E Coli Infection.

Is NCT04574596 still recruiting?

NCT04574596 is currently completed. Last updated 27 July 2021.

Last reviewed 2021-07-27 · How we verify

NCT04574596: SHREC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

Completed Last updated 27 July 2021

What this trial tests

trial testing no Intervention in E Coli Infection in 300 participants. Completed in 1 June 2021.

Timeline

12 November 2020

Primary endpoint
1 June 2021

1 June 2021

Quick facts

Lead sponsor	Duke University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	300
Start date	12 November 2020
Primary completion	1 June 2021
Estimated completion	1 June 2021
Sites	13 locations across United States

Drugs / interventions tested

no Intervention

Conditions studied

E Coli Infection — all drugs for E Coli Infection →

Sponsor

Duke University

Who can join

Eligibility, any sex, with E Coli Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, observational, multicenter, case-control study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of no Intervention

Trials testing the same drug.

NCT05856929 — Sexual Dysfunction After Renal Transplantation · unknown
NCT06222008 — Study on Symptom Clusters During Chemotherapy in Ovarian Cancer Patients With Different Chinese Medicine Constitution · unknown
NCT07464379 — Basic and Clinical Research of Pregnancy-Induced Hypertension · recruiting
NCT03933995 — Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction · unknown
NCT03172169 — Specific Small RNA in Plasma for Predicting Diaphragm Dysfunction in Mechanically Ventilated Patients · unknown

Other Duke University trials

Trials by the same sponsor.

NCT07216456 — Vaginal Dilator Therapy After Pelvic Radiation · NA · not yet recruiting
NCT07519317 — Dosing and Deployment Trial: A Home-based Optokinetic Treatment · NA · not yet recruiting
NCT07275359 — Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations · Phase 1 · not yet recruiting
NCT07216963 — The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · NA · not yet recruiting
NCT07459218 — IDEAS for Hope to Reduce Suicide Risk and Improve HIV Care Engagement in Tanzania · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04574596 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Duke University
Last refreshed: 27 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04574596.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing